P
ALNY icon

PensionDanmark’s Alnylam Pharmaceuticals ALNY Stock Holding History

PensionDanmark’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.76M Sell
22,451
-12,119
-35% -$3.66M 0.06% 290
2026
Q1 		$11.4M Sell
34,570
-1,692
-5% -$576K 0.11% 180
2025
Q4 		$14.4M Buy
+36,262
New +$16M 0.13% 135

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PensionDanmark's ALNY Position: Q2 2026 in Review

PensionDanmark reduced its Alnylam Pharmaceuticals (ALNY) stake by 35% in Q2 2026, selling an estimated $3.66M and leaving 22,451 shares worth $6.76M. The position accounts for 0.06% of the portfolio, ranked #290.

PensionDanmark first reported a position in ALNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $14.4M in Q4 2025. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • PensionDanmark held 22,451 shares of Alnylam Pharmaceuticals worth $6.76M as of Q2 2026.
  • PensionDanmark sold 12,119 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $3.66M.
  • Alnylam Pharmaceuticals made up 0.06% of PensionDanmark's portfolio in Q2 2026, its #290 holding.
  • PensionDanmark first reported a position in Alnylam Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • PensionDanmark's Alnylam Pharmaceuticals position peaked at $14.4M in Q4 2025.
  • 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on PensionDanmark's 13F filing for Q2 2026, filed 8 Jul 2026.